Related Experiment Video
Updated: Jul 1, 2026
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Identification of genes down-regulated during lung cancer progression: a cDNA array study
Mara Campioni1, Vincenzo Ambrogi, Eugenio Pompeo
1Department of Biochemistry and Biophysics F, Cedrangolo, Section of Pathology, Second University of Naples, Naples, Italy. maracampioni@yahoo.it
Journal of Experimental & Clinical Cancer Research : CR
|September 17, 2008
Summary
This study identified novel genes linked to non-small cell lung cancer (NSCLC) progression using cDNA arrays. Findings reveal changes in gene expression crucial for understanding lung cancer development and potential under-staging.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a significant global health issue.
- Stage I non-small cell lung cancer (NSCLC) survival rates (40-70%) suggest potential under-staging.
- Identifying molecular markers is crucial for improved diagnosis and treatment.
Purpose of the Study:
- To identify genes associated with lung cancer development and progression.
- To analyze gene expression patterns in early-stage NSCLC.
- To validate novel molecular markers for lung cancer.
Main Methods:
- cDNA array experiments were performed on 64 patients with stage 1 or 2 NSCLC.
- Quantitative RT-PCR was used to validate differentially expressed genes.
- Analysis focused on identifying genes involved in extracellular matrix, DNA repair, angiogenesis, cell cycle, and tumor suppression.
Main Results:
- 14 genes were found to be differentially regulated in NSCLC patients.
- 8 of these genes showed confirmed transcriptional regulation.
- Reduced expression of certain genes during lung cancer progression was identified and validated for the first time.
- Genes identified include those related to extracellular matrix (Decorin, MMP11), DNA repair (XRCC1), angiogenesis (VEGF), cell cycle (Cyclin D1), and tumor suppression (Semaphorin 3B, WNT-5A, Rb2/p130).
Conclusions:
- cDNA arrays effectively identified novel genes associated with NSCLC progression.
- The study confirmed previously known gene expression differences in NSCLC.
- This research provides new insights into the molecular mechanisms of lung cancer progression.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...